European Commission: President von der Leyen on the authorisation of the contract for vaccines with Pfizer and BioNTech

A safe and effective vaccine is our best chance to beat coronavirus and return to our normal lives.

In the past months, the European Commission has been working tirelessly to secure doses of potential vaccines.

And tomorrow we authorise a contract for up to 300 million doses of the vaccine developed by German company BioNTech and Pfizer. This is the most promising vaccine so far.

Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe. This will be the fourth contract with a pharmaceutical company to buy vaccines. And more will come. Because we need to have a broad portfolio of vaccines based on different technologies.

We have already started working with Member States to prepare national vaccination campaigns.

We are almost there. In the meantime, let us be prudent, and stay safe.


Tags assigned to this article:

You may have an interest in also reading…

IMF Blog: Digital Financial Inclusion in the Times of COVID-19

The COVID-19 pandemic could be a game changer for digital financial services. Low-income households and small firms can benefit greatly

IMF Blog: Financial Conditions Have Eased, but Insolvencies Loom Large

By Tobias Adrian and Fabio Natalucci Amid the human tragedy and economic recession caused by the COVID-19 pandemic, the recent surge in risk

WHO: World Humanitarian Day 2020 – A tribute to aid workers on the front lines

Amid a global pandemic, unprecedented needs and growing insecurity, aid workers and health-care responders are staying and delivering to the